Annual report on adverse events related with vaccines use in Calabria (Italy): 2012
- 1,
- 1,
- 1,
- 1,
- 1,
- 2,
- 1*
- 1Centro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro, and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
- 2Azienda Sanitaria Provinciale di Catanzaro, Italy.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Luca Gallelli
Centro Regionale di Informazione sul farmaco, AO Mater Domini, Catanzaro, and Department of Health Science, School of Medicine, University of Catanzaro, Italy.
Email: gallelli@unicz.it
Copyright: © 2013 The Author(s). This is an open access article.
Abstract
Vaccines are administered to large population of healthy individuals, particularly to millions of infants every year, through national immunization programs. Although vaccines represent a good defense against some infectious diseases, their administration may be related with the development of adverse vaccine events (AVEs); therefore their use is continually monitored to detect these side effects. In the presents work, we reported the suspected AVEs recorded in 2012 in Calabria, Italy. We performed a retrospective study on report forms of patients that developed AVEs in Calabria from January 1, 2012 to December 31, 2012. Naranjo score was used to evaluate the association between AVEs and vaccines and only suspected AVEs definable as certain, probable, or possible were included in this analysis. During the study period, we evaluated 461 records of adverse drug reactions (ADRs) and 18 (3.9%) were probably induced by vaccination. AVEs were common in females (almost 77.7%) and in children aged 0-3 years. The largest number of non-serious AVEs involved “skin and subcutaneous tissue disorders” and “general disorders and administration site conditions.” In conclusion, we documented that in Calabria the total number of AVEs is very low and it may be useful to increase the pharmacovigilance culture in order to evaluate the safety of these products in large populations.
Keywords
Subject
Recommended articles
- Dengue Virus: Molecular Biology and Recent Developments in Control Strategies, Prevention, Management, and Therapeutics
Almonther Abdullah Hershan · Journal of Pharmacology and Pharmacotherapeutics
- An Update on the Pharmacological Aspects of Vaccines and Antivirals for the Management of Monkeypox
Jerin James, Porkodi A, Kala P · Journal of Pharmacology and Pharmacotherapeutics
- Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies
Sweety Sharma, Somnath Basu, Ramesh K. Goyal · Journal of Pharmacology and Pharmacotherapeutics
- Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment
Pierandrea Rende, Laura Paletta, Giuseppe Gallelli · Journal of Pharmacology and Pharmacotherapeutics
- The safety of ketoprofen in different ages
Claudia Carbone, Pierandrea Rende, Pasquale Comberiati · Journal of Pharmacology and Pharmacotherapeutics
- Accidental staggered paracetamol overdose: An interesting case report
Kanakkande Aabideen, Lawrence Stephen Moulton, John Sills · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026